Spots Global Cancer Trial Database for chondrosarcoma
Every month we try and update this database with for chondrosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma | NCT02982486 | Soft Tissue Sar... Bone Sarcoma Chondrosarcoma Gastrointestina... Ewing's Tumor M... Ewing's Tumor R... Osteosarcoma Desmoplastic Sm... | Ipilimumab Nivolumab | 18 Years - | Assaf-Harofeh Medical Center | |
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma | NCT02982486 | Soft Tissue Sar... Bone Sarcoma Chondrosarcoma Gastrointestina... Ewing's Tumor M... Ewing's Tumor R... Osteosarcoma Desmoplastic Sm... | Ipilimumab Nivolumab | 18 Years - | Assaf-Harofeh Medical Center | |
| Apatinib for Inoperable Advanced Chondrosarcoma | NCT04260113 | Efficacy Toxicity, Drug | Apatinib Mesyla... | - | Peking University People's Hospital | |
| Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | NCT00413075 | Solid Tumor Lymphoma | oral belinostat | 18 Years - | Valerio Therapeutics | |
| Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation | NCT02073994 | Cholangiocarcin... Chondrosarcoma Glioma Other Advanced ... | AG-120 | 18 Years - | Servier | |
| Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas | NCT03715933 | Solid Tumors Malignant Pleur... Gastric Adenoca... Colorectal Aden... Sarcoma Pancreatic Aden... Ewing Sarcoma Chondrosarcoma GIST SDH-deficient S... | INBRX-109 Carboplatin Cisplatin Pemetrexed 5-fluorouracil Irinotecan Temozolomide | 12 Years - 85 Years | Inhibrx Biosciences, Inc | |
| Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery | NCT01553539 | Bone Cancer Chondrosarcoma Clear Cell Sarc... Metastatic Oste... Ovarian Sarcoma Recurrent Adult... Recurrent Osteo... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin... | therapeutic ang... laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors | NCT05039801 | Advanced Endome... Advanced Head a... Advanced Malign... Advanced Melano... Advanced Ovaria... Chondrosarcoma Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Recurrent Ovari... Refractory Endo... Refractory Head... Refractory Mela... Refractory Ovar... Refractory Ovar... Stage III Ovari... Stage III Uteri... Stage IIIA Ovar... Stage IIIA Uter... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Ovar... Stage IIIB Uter... Stage IIIC Ovar... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Ovaria... Stage IV Uterin... Stage IVA Ovari... Stage IVA Uteri... Stage IVB Ovari... Stage IVB Uteri... | Bevacizumab Glutaminase-1 I... Paclitaxel Capivasertib | 18 Years - | M.D. Anderson Cancer Center | |
| Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI | NCT01336803 | Bone Cancer Chondrosarcoma Ewing's Sarcoma Osteosarcoma Rhabdomyosarcom... Bone Necrosis Bone Sarcoma Osteomyelitis | Feraheme Magnetic Resona... | 10 Years - 21 Years | Stanford University | |
| Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial | NCT03173976 | Chondrosarcoma | Zoledronic Acid | 18 Years - | University of Iowa | |
| Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery | NCT05779670 | Osteosarcoma Ewing Sarcoma Chondrosarcoma Bone Tumor | 12 Years - 90 Years | Istituto Ortopedico Rizzoli | ||
| Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma | NCT00334854 | Childhood Malig... Sarcoma | doxorubicin hyd... ifosfamide adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma | NCT01330966 | Chondrosarcoma Metastatic Chon... | pazopanib | 18 Years - | George Clinical Pty Ltd | |
| Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum | NCT02587169 | Retroperitoneal... Retroperitoneal... Chondrosarcoma | Nilotinib-adria... | 18 Years - 70 Years | Broto, Javier Martín, M.D. | |
| Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations | NCT04521686 | Cholangiocarcin... Chondrosarcoma Glioma Any Solid Tumor | LY3410738 Gemcitabine Cisplatin Durvalumab | 18 Years - | Eli Lilly and Company | |
| Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | NCT00550654 | Kidney Cancer Melanoma (Skin) Metastatic Canc... Ovarian Cancer Sarcoma Unspecified Adu... | questionnaire a... 3-dimensional c... hypofractionate... image-guided ra... tomotherapy | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas | NCT04832620 | Bone Neoplasm o... Chordoma Chondrosarcoma Magnetic Resona... PET-CT Proton Therapy | 50 Years - | Leiden University Medical Center | ||
| Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration | NCT04040205 | Chondrosarcoma Osteosarcoma Soft Tissue Sar... | Abemaciclib | 18 Years - | Medical College of Wisconsin | |
| Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | NCT00413075 | Solid Tumor Lymphoma | oral belinostat | 18 Years - | Valerio Therapeutics | |
| Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma | NCT00949325 | Sarcoma | temsirolimus pl... | 1 Year - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas | NCT04055220 | Bone Sarcoma Osteosarcoma Ewing Sarcoma Chondrosarcoma Undifferentiate... Leiomyosarcoma Angiosarcoma | Treatment by Re... Treatment by Pl... | 12 Years - | Centre Leon Berard | |
| Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma | NCT01883518 | Sarcoma Neoplasms, Conn... | Autologous dend... | 18 Years - | N.N. Petrov National Medical Research Center of Oncology | |
| Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas | NCT03715933 | Solid Tumors Malignant Pleur... Gastric Adenoca... Colorectal Aden... Sarcoma Pancreatic Aden... Ewing Sarcoma Chondrosarcoma GIST SDH-deficient S... | INBRX-109 Carboplatin Cisplatin Pemetrexed 5-fluorouracil Irinotecan Temozolomide | 12 Years - 85 Years | Inhibrx Biosciences, Inc | |
| IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 | NCT01609179 | Basal Cell Carc... Chondrosarcoma | IPI-926 | 18 Years - | Infinity Pharmaceuticals, Inc. | |
| Proton Beam Therapy for Chondrosarcoma | NCT00496522 | Chondrosarcoma | Proton Beam The... | - | M.D. Anderson Cancer Center | |
| TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN Loss | NCT04690725 | Safety Issues Efficacy, Self | TQB3525 | 12 Years - | Peking University People's Hospital | |
| IPI-926 Extension Protocol for Continuation of Treatment With IPI-926 | NCT01609179 | Basal Cell Carc... Chondrosarcoma | IPI-926 | 18 Years - | Infinity Pharmaceuticals, Inc. | |
| YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma | NCT05448820 | Advanced Sarcom... Metastatic Sarc... Soft Tissue Sar... | YH001 Envafolimab Doxorubicin | 18 Years - | Tracon Pharmaceuticals Inc. | |
| Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies | NCT03474640 | Advanced Malign... | Toripalimab, Re... | 18 Years - | Shanghai Junshi Bioscience Co., Ltd. | |
| Proton Beam Therapy for Chondrosarcoma | NCT00496522 | Chondrosarcoma | Proton Beam The... | - | M.D. Anderson Cancer Center | |
| Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations | NCT04521686 | Cholangiocarcin... Chondrosarcoma Glioma Any Solid Tumor | LY3410738 Gemcitabine Cisplatin Durvalumab | 18 Years - | Eli Lilly and Company | |
| Apatinib for Inoperable Advanced Chondrosarcoma | NCT04260113 | Efficacy Toxicity, Drug | Apatinib Mesyla... | - | Peking University People's Hospital | |
| A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors | NCT04673942 | Solid Tumor, Ad... Cancer Neoplasms Sarcoma Sarcoma,Soft Ti... Chondrosarcoma | AdAPT-001 Checkpoint Inhi... | 18 Years - | EpicentRx, Inc. | |
| IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors | NCT05039801 | Advanced Endome... Advanced Head a... Advanced Malign... Advanced Melano... Advanced Ovaria... Chondrosarcoma Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Recurrent Ovari... Refractory Endo... Refractory Head... Refractory Mela... Refractory Ovar... Refractory Ovar... Stage III Ovari... Stage III Uteri... Stage IIIA Ovar... Stage IIIA Uter... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Ovar... Stage IIIB Uter... Stage IIIC Ovar... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Ovaria... Stage IV Uterin... Stage IVA Ovari... Stage IVA Uteri... Stage IVB Ovari... Stage IVB Uteri... | Bevacizumab Glutaminase-1 I... Paclitaxel Capivasertib | 18 Years - | M.D. Anderson Cancer Center | |
| Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies | NCT03474640 | Advanced Malign... | Toripalimab, Re... | 18 Years - | Shanghai Junshi Bioscience Co., Ltd. | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | NCT00413322 | Tumor | belinostat 5-Fluorouracil ... | 18 Years - | Valerio Therapeutics | |
| Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery | NCT01553539 | Bone Cancer Chondrosarcoma Clear Cell Sarc... Metastatic Oste... Ovarian Sarcoma Recurrent Adult... Recurrent Osteo... Recurrent Uteri... Stage III Adult... Stage III Uteri... Stage IV Adult ... Stage IV Uterin... | therapeutic ang... laboratory biom... | 18 Years - | Wake Forest University Health Sciences | |
| S9624 Ifosfamide in Treating Patients With Meningeal Tumors | NCT00003292 | Chondrosarcoma Adult Fibrosarc... Adult Leiomyosa... Adult Rhabdomyo... Adult Malignant... Adult Brain Mal... | ifosfamide | 18 Years - | SWOG Cancer Research Network | |
| Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base | NCT05861245 | Chordoma Chondrosarcoma | 5-fraction hipo... | 18 Years - | Quironsalud | |
| AG-120 in People With IDH1 Mutant Chondrosarcoma | NCT04278781 | Chondrosarcoma Chondrosarcoma,... Chondrosarcoma,... IDH1 Gene Mutat... | AG-120 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine | NCT00592748 | Chordoma Chondrosarcoma | Charged Particl... | 18 Years - | Massachusetts General Hospital | |
| Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas | NCT03442465 | Bone Sarcoma Osteosarcoma Chondrosarcoma Ewing's Sarcoma Osseous Sarcoma Bone Neoplasm | Toronto Extremi... Musculoskeletal... Timed Get Up an... Orthogonal Radi... Weight Bearing ... Range of Motion | 4 Years - | Memorial Sloan Kettering Cancer Center | |
| Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors | NCT01560260 | Carney Complex Chondrosarcoma Gastrointestina... Paraganglioma | Laboratory Biom... Linsitinib Pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| S9624 Ifosfamide in Treating Patients With Meningeal Tumors | NCT00003292 | Chondrosarcoma Adult Fibrosarc... Adult Leiomyosa... Adult Rhabdomyo... Adult Malignant... Adult Brain Mal... | ifosfamide | 18 Years - | SWOG Cancer Research Network | |
| Low Grade Chondrosarcoma Versus Enchondroma | NCT02996747 | Chondroma Chondrosarcoma | curettage (intr... | - | Istituto Ortopedico Rizzoli | |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer | NCT01132547 | Cancer | cyproheptadine ... placebo | 2 Years - 21 Years | University of South Florida | |
| Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery | NCT00450736 | Childhood Malig... Sarcoma | celecoxib adjuvant therap... radiation thera... | 18 Years - 120 Years | University of Miami | |
| TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN Loss | NCT04690725 | Safety Issues Efficacy, Self | TQB3525 | 12 Years - | Peking University People's Hospital | |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas | NCT04055220 | Bone Sarcoma Osteosarcoma Ewing Sarcoma Chondrosarcoma Undifferentiate... Leiomyosarcoma Angiosarcoma | Treatment by Re... Treatment by Pl... | 12 Years - | Centre Leon Berard | |
| Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma | NCT00334854 | Childhood Malig... Sarcoma | doxorubicin hyd... ifosfamide adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma | NCT05193188 | Chondrosarcoma | Anlotinib hydro... PD-1 inhibitor | 18 Years - 100 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Long-Term Longitudinal QoL in Patients Undergoing EEA | NCT04087902 | Pituitary Tumor Meningioma Rathke Cleft Cy... Chordoma Chondrosarcoma Craniopharyngio... Encephalocele Esthesioneurobl... | 18 Years - | Ohio State University | ||
| Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Low and Inter-mediate Grade Chondrosarcoma of the Skull Base | NCT01182753 | Chondrosarcoma | carbon ion ther... proton therapy | 18 Years - 80 Years | Heidelberg University | |
| Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use | NCT03491371 | Efficacy Toxicity | Methylsulfonic ... | - | Peking University People's Hospital | |
| Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas | NCT05131386 | Soft Tissue Sar... Bone Tumors Small Round-cel... | Trabectedin | 16 Years - 75 Years | Grupo Espanol de Investigacion en Sarcomas | |
| Proton Beam Therapy for Chondrosarcoma | NCT00496522 | Chondrosarcoma | Proton Beam The... | - | M.D. Anderson Cancer Center | |
| Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone | NCT05033288 | Bone Sarcoma Chondrosarcoma Chordoma Ewing Sarcoma o... Pelvic Rhabdomy... | Electronic Heal... Quality-of-Life... | 15 Years - | Mayo Clinic | |
| Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain | NCT00550654 | Kidney Cancer Melanoma (Skin) Metastatic Canc... Ovarian Cancer Sarcoma Unspecified Adu... | questionnaire a... 3-dimensional c... hypofractionate... image-guided ra... tomotherapy | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Understanding Engagement Trends in Chondrosarcoma Clinical Trials | NCT06029478 | Chondrosarcoma | 18 Years - | Power Life Sciences Inc. | ||
| Alanosine in Treating Patients With Cancer | NCT00062283 | Lung Cancer Malignant Mesot... Pancreatic Canc... Sarcoma | L-alanosine | 13 Years - | National Cancer Institute (NCI) | |
| S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone | NCT00096213 | Sarcoma | conventional su... | 18 Years - | SWOG Cancer Research Network | |
| Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy | NCT06029218 | Chordoma Chondrosarcoma Ewing Sarcoma Osteosarcoma | Proteus ONE one... Proteus ONE two... | 18 Years - | Centre Antoine Lacassagne | |
| Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma | NCT00949325 | Sarcoma | temsirolimus pl... | 1 Year - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas | NCT05131386 | Soft Tissue Sar... Bone Tumors Small Round-cel... | Trabectedin | 16 Years - 75 Years | Grupo Espanol de Investigacion en Sarcomas | |
| S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone | NCT00096213 | Sarcoma | conventional su... | 18 Years - | SWOG Cancer Research Network | |
| Neutrophils in Bone Sarcomas | NCT04867421 | Osteosarcoma, C... | No intervention | 18 Years - | Université de Reims Champagne-Ardenne | |
| IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors | NCT05039801 | Advanced Endome... Advanced Head a... Advanced Malign... Advanced Melano... Advanced Ovaria... Chondrosarcoma Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Recurrent Ovari... Refractory Endo... Refractory Head... Refractory Mela... Refractory Ovar... Refractory Ovar... Stage III Ovari... Stage III Uteri... Stage IIIA Ovar... Stage IIIA Uter... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Ovar... Stage IIIB Uter... Stage IIIC Ovar... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Ovaria... Stage IV Uterin... Stage IVA Ovari... Stage IVA Uteri... Stage IVB Ovari... Stage IVB Uteri... | Bevacizumab Glutaminase-1 I... Paclitaxel Capivasertib | 18 Years - | M.D. Anderson Cancer Center | |
| AG-120 in People With IDH1 Mutant Chondrosarcoma | NCT04278781 | Chondrosarcoma Chondrosarcoma,... Chondrosarcoma,... IDH1 Gene Mutat... | AG-120 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g) | NCT00543712 | Chondrosarcoma | PRO95780 | 18 Years - | Genentech, Inc. | |
| Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery | NCT00450736 | Childhood Malig... Sarcoma | celecoxib adjuvant therap... radiation thera... | 18 Years - 120 Years | University of Miami |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
